Changing Services, Changing Oncology Pharmacy COVID-19- An Service Update Survey
In 2020, in response to the COVID pandemic and the impact on cancer care, BOPA produced a statement outlining recommendations for possible changes to both clinical and operational oncology pharmacy practice.
These changes were accompanied by considerations, potential impacts and wider discussions around management of cancer patients during the COVID pandemic. As part of BOPAs mission to continue to review and reflect, we are now asking the members to complete a short survey (3-5 min) in order to have a broad understanding within oncology pharmacy, around which recommendations were implemented, which ones have been continued and challenges of the implementation and ongoing use. This information is essential in the ability of BOPA and the oncology pharmacy community to reflect on lessons learnt during the COVID pandemic. This will help us all plan for the future, both as part of contingency planning for future pandemics and now, when we are facing significant capacity challenges. We intend on publishing this learning in the new year
Much appreciated
GAP subcommittee
